Genpact G
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Genpact (G) Business Model and Operations Summary
Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. It is a General Electric spin-off, which is still a large source of revenue for Genpact.
Key Insights
Genpact (G) Core Market Data and Business Metrics
Latest Closing Price
$47.07Market Cap
$8.27 BillionPrice-Earnings Ratio
12.93Total Outstanding Shares
175.67 Million SharesTotal Employees
140,000Dividend
$0.17 Per Share QuarterlyIPO Date
August 2, 2007SIC Description
Services-management Consulting ServicesPrimary Exchange
New York Stock ExchangeHeadquarters
Canon's Court, Hamilton, D0, HM 12
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Financing Activities, Continuing | $-52.15 Million |
Net Cash Flow From Operating Activities | $604.08 Million |
Net Cash Flow | $468.35 Million |
Net Cash Flow From Financing Activities | $-52.15 Million |
Net Cash Flow, Continuing | $468.35 Million |
Net Cash Flow From Investing Activities, Continuing | $-83.58 Million |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Income/Loss From Continuing Operations After Tax | $663.06 Million |
Income/Loss From Continuing Operations Before Tax | $652.75 Million |
Diluted Average Shares | $180.26 Million |
Operating Expenses | $977.23 Million |
Basic Average Shares | $178.76 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $0 |
Comprehensive Income
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Comprehensive Income/Loss | $668.77 Million |
Comprehensive Income/Loss Attributable To Parent | $668.77 Million |
Other Comprehensive Income/Loss | $5.71 Million |
Other Comprehensive Income/Loss Attributable To Parent | $5.71 Million |
Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Liabilities | $2.93 Billion |
Other Non-current Liabilities | $8.73 Million |
Fixed Assets | $207.59 Million |
Long-term Debt | $1.63 Billion |
Current Assets | $2.40 Billion |
Wages | $280.91 Million |
Historical Dividends
Current dividend: $0.17 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Feb 6, 2025 | Mar 26, 2025 | Mar 11, 2025 | $0.17 | Quarterly |
Oct 17, 2024 | Dec 23, 2024 | Dec 9, 2024 | $0.1525 | Quarterly |
Jul 11, 2024 | Sep 25, 2024 | Sep 11, 2024 | $0.1525 | Quarterly |
May 2, 2024 | Jun 26, 2024 | Jun 10, 2024 | $0.1525 | Quarterly |
Feb 8, 2024 | Mar 26, 2024 | Mar 11, 2024 | $0.1525 | Quarterly |
Oct 26, 2023 | Dec 22, 2023 | Dec 8, 2023 | $0.1375 | Quarterly |